Navigation Links
Mirena Lawsuits Mount, as Bernstein Liebhard LLP Notes More than 400 Mirena IUD Lawsuit Filings in State, Federal Litigations
Date:10/31/2013

New York, NY (PRWEB) October 31, 2013

Mirena lawsuit (http://www.themirenalawsuitcenter.com/) claims continue to mount in courts throughout the country, as Bernstein Liebhard LLP notes that claims filed in state and federal litigations have surpassed 400. According to court records filed in U.S. District Court, Southern District of New York, at least 211 Mirena IUD lawsuits have now been filed in the multidistrict litigation underway in that district, an increase of more than 50 in just the past month. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434) An additional 219 claims filed on behalf of alleged victims of serious Mirena complications related to spontaneous migration of the IUD are also pending in a multicounty litigation established in New Jersey’s Bergen County Superior Court. In August, court records indicated that only 180 such claims had been filed in the proceeding. (In Re: Mirena Litigation; Case No. 297)

“Our Firm hears from women on a regular basis who have allegedly suffered serious Mirena complications, including uterine perforations, organ damage, scarring, and infertility, following spontaneous migration of their IUD. We are not surprised that more than 400 Mirena IUD lawsuits have been filed, and expect the number to increase in the coming months,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena IUD lawsuit evaluations to women who allege serious injuries due to this device.

Mirena IUD Lawsuits
The Mirena IUD was launched on the U.S. market in 2000, after the U.S. Food & Drug Administration (FDA) cleared the device for use as a contraceptive. In 2009, the FDA expanded its approved uses to include the treatment of heavy menstrual bleeding in women who wish to use an IUD as their primary method of birth control. That same year, the agency issued a Warning Letter to Bayer Healthcare Pharmaceuticals, after the FDA found that one of the company’s Mirena promotions made misleading claims about the safety and efficacy of the IUD. According to a report that aired on 7 Action News this past summer, the FDA has received more than 70,000 complaints involving Mirena, including thousands that detail cases of device dislocation and uterine perforation, since the device came on the market in 2000.*

According to court documents, plaintiffs in Mirena lawsuits have allegedly suffered uterine perforations and embedment, ectopic pregnancy, infections, infertility, scarring and other serious injuries, some of which required surgical invention, due to spontaneous migration of the Mirena IUD. Bayer is also accused of overstating the IUD’s efficacy and downplaying the risks of serious Mirena complications. Court records indicate that a Case Management Conference is scheduled to be held in the New Jersey Mirena litigation on November 20, 2013. A Status Conference for Mirena IUD lawsuits will be convened in the Southern District of New York on the following day.

Alleged victims of Mirena complications may be entitled to file a Mirena lawsuit in order to obtain compensation for their medical bills, lost wages, pain and suffering and other damages. Learn More about the issues involved in Mirena IUD lawsuits at Bernstein Liebhard LLP’s website. To arrange for a free evaluation of your claim, please call 800-511-5092.

*wxyz.com/dpp/news/local_news/investigations/thousands-of-women-complain-about-dangerous-complications-from-mirena-iud-birth-control, 7 Action News, August 27, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for
this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.themirenalawsuitcenter.com/

Read the full story at http://www.prweb.com/releases/mirena-lawsuit/mirena-iud-lawsuit/prweb11290744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mirena IUD Lawsuit Help Update: Resource4thePeople Comments on New Developments in State and Federal Court Litigation
2. Injury Lawyer Comments on the Growing Number of Mirena IUD Lawsuits
3. U.S. Federal Panel Vacates Order to Transfer Mirena Lawsuit to New York Litigation, Bernstein Liebhard LLP Reports
4. DrugRisk Alerts of New Rise In Mirena Lawsuits Alleging Uterine Damage
5. Mirena Lawsuits Progress in State, Federal Litigations, Bernstein Liebhard LLP Reports
6. Mirena IUD Lawsuits Move Forward, With Issuance of New Case Management Orders in New Jersey Litigation, Bernstein Liebhard LLP Reports
7. Mirena Lawsuit Update: Bernstein Liebhard LLP Reports on Growing Number of Mirena IUD Lawsuits Pending in Federal Multidistrict Litigation
8. Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in New Jersey Mirena Litigation
9. Arkansas Woman’s Mirena IUD Migrated Outside of Uterus, Prompting Need for Surgery, Alleges Parker Waichman LLP in Lawsuit
10. Parker Waichman LLP Represents Wisconsin Woman in Lawsuit Alleging Mirena IUD Perforated her Uterus, Causing Serious Pain and Injuries
11. DrugNews: Federal Court Moves Growing Mirena Lawsuits Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Yorba Linda, Ca (PRWEB) , ... March 29, ... ... a standard process in many scientific laboratories. The assembly protocols involve many repetitive ... is well suited for automation, which enables the high-throughput needed, and results in ...
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of the University of Pennsylvania ... have made a $10 million gift to establish the Ken Moelis and Julie ... pathway to a Wharton MBA for highly-qualified Penn undergraduates whose academic and career interests ...
(Date:3/28/2017)... ... March 28, 2017 , ... For many women, getting birth control isn’t as easy as ... they either don’t have access to a health care facility or a pharmacy within 60 ... of the United States or for many who are faced with health or personal issues ...
(Date:3/28/2017)... ... ... The Thyroid Secret is a specialized 9-part documentary series ... recently launched on March 1, and Dr. Wentz discussed varied benefits and aspects ... Wentz is a licensed pharmacist and a foremost thyroid specialist. After being diagnosed ...
(Date:3/28/2017)... ... March 28, 2017 , ... Via Oncology, the leading provider ... a free, public-facing tool for analyzing the costs of various drug regimens in ... information to patients, providers, insurers and pharmaceutical companies about the estimated costs of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TAIPEI, Taiwan , March 28, 2017 /PRNewswire/ ... medical device company, is pleased to announce ... Series A investment of Panther Orthopedics, Inc., a ... pioneering innovative dynamic fixation solutions for orthopedic extremity ... market continues to expand rapidly, primarily due to ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... -- Orexigen Therapeutics, Inc. (Nasdaq: OREX ) today ... and year ended December 31, 2016. ... Orexigen, beginning with the re-acquisition of the rights to ... team at Orexigen demonstrated remarkable focus, executing on a ... our Company while rewarding us full control of our ...
Breaking Medicine Technology: